NCT06529705View on ClinicalTrials.gov

Performance and Safety Evaluation of the EkiYou V2 Application in Patients With Diabetes Using Multiple Daily Insulin Injections (EkiYou-Study1)

NACompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

August 19, 2024

Primary Completion Date

March 27, 2025

Study Completion Date

March 27, 2025

Conditions
Diabetes Type 1Diabetes Type 2 on InsulinPancreatogenous Diabetes
Interventions
DEVICE

EkiYou V2

Use of a mobile application that help users to evaluate their daily bolus and basal insulin needs, and that adjusts at weekly basis their insulin to carb ratios, correction factor and basal dose.

Trial Locations (1)

34000

Centre Hospitalier Universitaire de Montpellier, Montpellier

All Listed Sponsors
collaborator

DiappyMed

INDUSTRY

lead

University Hospital, Montpellier

OTHER

NCT06529705 - Performance and Safety Evaluation of the EkiYou V2 Application in Patients With Diabetes Using Multiple Daily Insulin Injections (EkiYou-Study1) | Biotech Hunter | Biotech Hunter